News
There have been almost 50,000 cases of RSV recorded this year, but only a select group can access the free vaccine, with ...
The American Academy of Pediatrics has said childhood vaccines are carefully studied in randomized controlled trials — ...
We came across a bullish thesis on Sanofi (SNY) on Substack by Business Model Mastery. In this article, we will summarize the ...
It teased the positive results in July. Along with Beyfortus (nirsevimab), it is also a potential rival to Pfizer's RSV vaccine Abrysvo, which can be given to women during pregnancy to protect ...
Beyfortus, and GSK’s Rotarix and Merck’s RotaTeq, the two rotavirus vaccines licensed for use in the United States. Some of the currently available vaccines were tested by comparing them to ...
AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody ...
Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ETCompany ParticipantsKatie Falzone - Senior Vice President, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results